Resources
AVAC has developed a variety of resources for policymakers, health care providers, and our immunization partners. Explore all of the resources below or use our filters to narrow your search by type of resource and by type of policy.
-
August 13, 2026AVAC Statement on the National Vaccine Advisory Committee
AVAC is concerned about recent changes to the National Vaccine Advisory Committee (NVAC) charter that seek to expand its work beyond vaccines and immunization. With HHS now also soliciting nominations for new committee members, AVAC is urging the department to keep NVAC focused on its core mission of vaccines and immunization. For decades, NVAC has […]
Letters to Administration
July 14, 2026AVAC Statement on Pending Public Health Leadership Nominations in the United States Senate
AVAC issued a statement ahead of the Senate hearing on nominees to lead the Centers for Disease Control and Prevention (CDC) and the Administration for Strategic Preparedness and Response (ASPR). Read the full statement.
Letters to Administration
May 26, 2026AVAC Comments to FDA on Vaccine and Related Biological Product Advisory Committee May Meeting
AVAC comments provided to the Food and Drug Administration (FDA) in advance of the Vaccine and Related Biological Product Advisory Committee (VRBPAC) meeting on May 28, 2026. Read the full letter.
Letters to Administration
April 14, 2026AVAC Statement Ahead of HHS Secretary Kennedy’s Congressional Hearings on the Fiscal Year 2027 Budget
AVAC issued a statement ahead of HHS Secretary Kennedy’s FY2027 budget hearings, highlighting the importance of protecting Americans’ access to vaccines. Read the full statement.
Letters to Administration
March 13, 2026AVAC Comments Regarding Proposed Changes to Existing Measure for HEDIS
AVAC comments sharing support for the National Committee for Quality Assurance (NCQA) Proposed Changes to Existing Measure for HEDIS MY 2026: Adult Immunization Status (AIS). Read the full letter.
Regulatory Comments
March 13, 2026AVAC Comments to CMS on Patient Protection and Affordable Care Act; and more
AVAC comments to the Centers of Medicare & Medicaid Services (CMS) on the Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program. Read the full letter.
Letters to Administration
March 12, 2026AVAC Comments to ACIP: March 2026
AVAC comments submitted in advance of the Advisory Committee on Immunization Practices (ACIP) meeting scheduled for March 18-19 (which was later postponed). Read the full letter.
Regulatory Comments
March 11, 2026AVAC Comments to FDA on Vaccine and Related Biological Product Advisory Committee Meeting
AVAC comments provided to the Food and Drug Administration (FDA) in advance of the Vaccine and Related Biological Product Advisory Committee (VRBPAC) meeting on March 12, 2026. Read the full letter.
Letters to Administration
February 18, 2026Influenza’s Economic Burden and the Impact of Adult Vaccination
Study An AVAC-funded study from Global Healthy Living Foundation (GHLF) found that influenza cost the U.S. economy nearly $29 billion in the 2023-2024 flu season. Higher adult vaccination rates could have prevented tens of thousands of deaths. Read the study Read the white paper Fact Sheet Vaccination Saves Lives and Billions in Health Care and […]
Fact Sheets Benefits of Immunization
December 20, 2025AVAC Quarterly Update Newsletter (December 2025)
Check out the latest resources and news from AVAC here.
Newsletter